Innovation is at the heart of everything we do at Douglas Pharmaceuticals. Our extensive experience in product development has enabled us to create a portfolio of successful therapies that have made a real difference in patients’ lives.
Douglas has a robust portfolio of innovative projects in various therapeutic areas. We’re seeking co-development partners with complementary expertise and resources to accelerate the development and commercialization of these promising therapies.
Our pipelines
505(j) Complex Generic Pipeline
Douglas has several projects in the pre-formulation or formulation development stage. Douglas specializes in specialty generic product development such as soft-gelatin capsules that have technical, clinical or IP complexity.
For more information on our co-development opportunities, please contact us.
505(b)(2) Pipeline
Douglas specializes in the development of 505(b)(2) alternative formulation products to meet unmet needs in populations of paediatric, geriatric and patients with swallowing difficulties.
We are open to collaboration on these oral liquid opportunities focusing on the US market.
Why partner with Douglas?
We offer a unique blend of expertise, resources, and a proven track record of success, making us an ideal partner for co-development ventures. Here’s what sets us apart:
Ready to explore a co-development partnership?
Contact us to discuss your project and how we can work together to bring your healthcare innovation to life.